Verona Pharma plc

VRNADelisted Oct 7, 2025

Industry: Pharmaceutical Preparations
SEC CIK: 0001657312

SEC filings (opens in a new tab)

Verona Pharma plc was delisted on Oct 7, 2025; its insiders filed their last Form 4 on Oct 8, 2025; 243 institutions reported holding it in 13F filings for Q3 2025, worth $8.57B in total; superinvestors Duquesne Family Office and Soros Fund Management held it.

Q3 2022 vs. Q2 2022

How the institutions holding Verona Pharma plc changed between Q2 2022 and Q3 2022.

All holders in Q3 2022 All holders in Q2 2022

13F holders of VRNA: Q2 2022 compared with Q3 2022
Measure	Q2 2022	Of which not filed for Q3 2022	Q3 2022	Change
Holders	40	1	68	+29
Shares	35.1M	726	52.1M	+17.0M (+48.4%)
Value	$145.9M	$3.00K	$529.0M	+$383.1M (+262.6%)

1 institution that held it in Q2 2022 haven't filed for Q3 2022 yet. Not filing isn't selling, so the changes leave them out.

New holders (35)

Institutions that held Verona Pharma plc at the end of Q3 2022 but not at the end of Q2 2022.

Institutions new to VRNA in Q3 2022
Institution	Shares	Value	% of portfolio
Deep Track Capital, LP	2,829,094	$28.9M	1.43%
Frazier Life Sciences Management, L.P.	2,099,541	$21.5M	1.65%
Octagon Capital Advisors LP	1,324,868	$13.5M	2.34%
Adage Capital Partners GP, L.L.C.	431,816	$4.41M	0.01%
State Street Corp	449,029	$4.23M	0.00%
FMR LLC	413,400	$4.22M	0.00%
Altium Capital Management LP	404,000	$4.13M	1.55%
Two Sigma Investments, LP	360,550	$3.69M	0.01%
Affinity Asset Advisors, LLC	350,000	$3.58M	1.65%
Parkman Healthcare Partners LLC	323,273	$3.30M	0.94%
Janus Henderson Group PLC	300,000	$3.07M	0.00%
ExodusPoint Capital Management, LP	239,602	$2.45M	0.03%
Moody Aldrich Partners LLC	227,989	$2.33M	0.48%
Two Sigma Advisers, LP	153,400	$1.57M	0.00%
ACT Capital Management, LLC	143,500	$1.47M	2.02%
Sphera Funds Management Ltd.	120,000	$1.23M	0.22%
UBS Oconnor LLC	111,926	$1.14M	0.01%
Pura Vida Investments, LLC	100,000	$1.02M	0.15%
Millennium Management LLC	79,340	$811.0K	0.00%
1492 Capital Management LLC	65,862	$673.0K	0.49%
JPMorgan Chase & Co	63,279	$647.0K	0.00%
Cubist Systematic Strategies, LLC	42,877	$438.0K	0.00%
Vanguard Group Inc	41,704	$426.0K	0.00%
Jump Financial, LLC	40,800	$417.0K	0.02%
AlphaCentric Advisors LLC	40,000	$409.0K	0.42%
Glenmede Trust Co NA	30,215	$308.0K	0.00%
Bank of New York Mellon Corp	24,850	$254.0K	0.00%
Envestnet Asset Management Inc	16,192	$165.0K	0.00%
SEI Investments Co	13,460	$138.0K	0.00%
Brinker Capital Investments, LLC	12,326	$126.0K	0.00%
UBS Group AG	778	$8.00K	0.00%
Royal Bank of Canada	726	$7.00K	0.00%
Cutler Group LP	392	$4.00K	0.00%
Advisor Group Holdings, Inc.	346	$3.00K	0.00%
Wells Fargo & Company	100	$1.00K	0.00%

Sold out (6)

Institutions that held Verona Pharma plc at the end of Q2 2022 and filed for Q3 2022 without it.

Institutions that sold out of VRNA in Q3 2022
Institution	Shares, Q2 2022	Value, Q2 2022
Novo Holdings A/S	761,205	$3.19M
Tekla Capital Management LLC	751,905	$3.15M
venBio Partners LLC	161,897	$678.0K
IPG Investment Advisors LLC	11,900	$50.0K
Simplex Trading, LLC	7,866	$32.0K
CoreCap Advisors, LLC	600	$3.00K

Not filed for Q3 2022 yet (1)

Institutions that held Verona Pharma plc at the end of Q2 2022 and haven't filed a 13F for Q3 2022. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding VRNA in Q2 2022 that haven't filed for Q3 2022
Institution	Shares, Q2 2022	Value, Q2 2022
Brewin Dolphin Ltd	726	$3.00K